1, 5-disubstituted-4-bromopyrazole compound as well as preparation method and application thereof
By performing a selective bromination reaction of enamine ketone compounds, hydrazine compounds and brominated reagents under photocatalytic conditions, the problems of limited substrate range and narrow functional group compatibility in the prior art were solved, and 1,5 -High-efficiency, pure and high preparation of disubstituted-4-bromopyrazole, suitable for the application of a variety of drug intermediates.
Patent Information
- Application Number
- CN202411124749.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-15
AI Technical Summary
The existing methods for synthesis of bromopyrazole are limited in the range of substrates and the functional group compatibility is narrow, which limits the expansion of the reaction.
The ring-forming and regioselective bromination reaction was carried out using enamine ketone compounds, hydrazine compounds, bromination reagents, photocatalysts and polar organic solvents to obtain 1,5-disubstituted-4-bromopyrazole compounds. Methods Simple, mild conditions, wide range of substrates, good tolerance to functional groups.
It has achieved efficient preparation of 1,5-disubstituted-4-bromopyrazole compounds, with high yields, purity up to 98.5-99.9%, high reaction efficiency, economical steps, and suitable for the preparation of pharmaceutical and pesticide intermediates.
Smart Images

Figure BDA0004996207340000011 
Figure BDA0004996207340000012 
Figure BDA0004996207340000021
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and specifically relates to a 1,5-disubstituted-4-bromopyrazole compound and a preparation method and application thereof. Background Art
[0002] Pyrazole, as a five-membered heterocyclic skeleton containing dinitrogen, has good biological activity and is regarded as a dominant skeleton for the development of medicines and pesticides. For example, vesasone has analgesic and central nervous system depressant properties, tepoxalin, deracoxib and celecoxib have analgesic and antipyretic activities, and penthiopyrad has potential antifungal activity for controlling plant diseases. In addition, pyrazole is also used as a reaction building block, chiral auxiliary and important directing group. In view of the multiple functions of pyrazole derivatives, it is of great significance to explore simple and practical methods to construct pyrazole derivatives with a variety of substituents.
[0003] At present, the methods for synthesizing brominated pyrazole derivatives mainly include:
[0004] (a) GG Levkovskaya et al. (Levkovskaya, GG, Bozhenkov, GV, Larina, LI, Mirskova, A N. New Synthesis and Properties of 3-Alkyl-, 3-Chloroalkyl-, 3-Perfluoroalkyl-, and 3-Aryl-1-methyl-(5-halo)pyrazoles from Chloro(bromo)vinylKetones and N,N-Dimethylhydrazine [J]. Russian Journal of Organic Chemistry, 2002, 38: 1501-1506. DOI: 10.1023 / a: 1022564707537) reported that 2,2-dibromo(chloro)vinyl ketone and N,N-dimethylhydrazine were used as substrates to generate 3-substituted 1-methyl(5-halo)pyrazole compounds through demethylation. The reaction formula is:
[0005]
[0006] (b) Yang Yiwen et al. (Yang Y, Kuang C, Jin H, Yang Q, Zhang Z. Efficient synthesis of 1,3-diaryl-4-halo-1H-pyrazoles from 3-arylsydnones and 2-aryl-1,1-dihalo-1-alkenes [J]. Beilstein Journal of Organic Chemistry, 2011, 7 (1): 1656-1662. DOI: 10.3762 / bjoc.7.195.) reported that 1,1-dihalo-2-arylethenes and 3-arylsydnones were used as substrates. After the action of base, 1,3-diaryl-4-halopyrazole compounds can be conveniently and effectively synthesized. However, the functional group compatibility range of dihaloalkenes is narrow, which limits the expansion of the substrate range. The reaction formula is:
[0007]
[0008] (c) Ramesh C. Samanta et al. (Samanta RC, Yamamoto H. Selective halogenation using an aniline catalyst [J]. Chemistry-A European Journal, 2015, 21 (34): 11976-11979. DOI: 10.1002 / chem.201502234.) reported the use of aniline as a catalyst for selective halogenation and N-bromosuccinimide as a bromine source for the selective halogenation of aromatic and heteroaromatic compounds and unactivated double bonds to obtain 4-bromo-1-phenyl-1H-pyrazole, such as:
[0009]
[0010] (d) Targos K et al. (Targos K, Williams OP, Wickens Z K. Unveiling potent photooxidation behavior of catalytic photoreductants [J]. Journal of the American Chemical Society, 2021, 143 (11): 4125-4132. DOI: 10.1021 / jacs.1c00399.) reported the release of effective photooxidant behavior from the most reductive conventional photoredox catalyst PTH (N-phenylphenothiazine). This method can be used to oxidize C (SP) by photooxidation of aromatic substrates.2 )-N coupling to obtain 4-bromo-1-phenyl-1H-pyrazole, for example:
[0011]
[0012] However, the above four methods either use halogenated olefins or use pyrazole and bromopyrazole as raw materials, but there are few types of raw materials to choose from and there is a problem of limited substrate range. Summary of the invention
[0013] In view of this, the object of the present invention is to provide a 1,5-disubstituted-4-bromopyrazole compound and a preparation method and application thereof. The preparation method of the present invention has the advantages of a wide substrate range and good functional group tolerance, and the method is simple and the conditions are mild.
[0014] The present invention provides a method for preparing a 1,5-disubstituted-4-bromopyrazole compound, comprising the following steps:
[0015] An enaminone compound, a hydrazine compound, a bromination agent, a photocatalyst, an additive and a polar organic solvent are mixed to carry out a ring-forming and regioselective bromination reaction to obtain a 1,5-disubstituted-4-bromopyrazole compound;
[0016] The enaminone compound has a structure shown in Formula I, the hydrazine compound has a structure shown in Formula II, and the 1,5-disubstituted-4-bromopyrazole compound has a structure shown in Formula III:
[0017]
[0018] R1 is aryl, substituted aryl or alkyl; R2 is aryl, substituted aryl, hydrogen or acyl.
[0019] Preferably, R1 includes phenyl, halogenphenyl, trifluoromethylphenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, cyanophenyl, naphthyl, biphenyl, methylenedioxyphenyl, furyl, pyridyl, isopropyl, propyl, tridecyl, cyclopropyl, cyclobutyl, cyclohexyl or adamantyl.
[0020] Preferably, the enaminones include (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-fluorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-chlorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-bromophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-iodophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-trifluoromethylphenyl)-2-propene-1-one, (E)-3-( (E)-3-(dimethylamino)-1-(4-nitrophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(4-methoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(4-ethoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-methylphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-cyanophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(2-bromophenyl)- phenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(3,4-chlorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-naphthyl-2-propene-1-one, (E)-3-(dimethylamino)-1-(6-methoxynaphthyl-2-yl)-2-propene-1-one, 3-(dimethylamino)-1-biphenyl-2-propene-1-one, (E)-3-(dimethylamino)-1-(benzo[d][1,3]dioxol-5-yl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(furan-2-yl)-2-propene-1-one , 3-(dimethylamino)-1-(2-pyridine)-2-propene-1-one, 3-(dimethylamino)-1-isopropyl-2-propene-1-one, 3-(dimethylamino)-1-propyl-2-propene-1-one, 3-(dimethylamino)-1-tridecyl-2-propene-1-one, 3-(dimethylamino)-1-cyclopropyl-2-propene-1-one, 3-(dimethylamino)-1-cyclobutyl-2-propene-1-one, 3-(dimethylamino)-1-cyclohexyl-2-propene-1-one or 3-(dimethylamino)-1-((3r, 5r, 7r)-adamantan-1-yl)-2-propene-1-one.
[0021] Preferably, R2 includes phenyl, halophenyl, cyanophenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, naphthyl, pyridyl, pyrazinyl, benzyl, hydrogen, phenylsulfonyl or isobutyric acid acyl.
[0022] Preferably, the hydrazine compound includes phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-trifluoromethylphenylhydrazine, 4-methoxyphenylhydrazine, 3-fluorophenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-nitrophenylhydrazine, 4-nitrophenylhydrazine, 3-methoxyphenylhydrazine, 2-methylphenylhydrazine, 2-fluorophenylhydrazine, 3,5-dimethylphenylhydrazine, 3,4-dichlorophenylhydrazine, 1-benzylhydrazine, 1-naphthyhydrazine, 2-hydrazinopyridine, 2-hydrazinopyrazine, hydrazine hydrate, benzenesulfonylhydrazine or isobutyric acid hydrazide.
[0023] Preferably, the bromination reagent comprises carbon tetrabromide or N-bromosuccinimide, and the molar ratio of the enaminone compound, the hydrazine compound and carbon tetrabromide is 1:(1-3):(1-3).
[0024] Preferably, the photocatalyst is tris(2-phenylpyridine)iridium, tris(2,2'-bipyridyl)ruthenium(II) chloride hexahydrate, di[2-(2,4-difluorophenyl)-5-trifluoromethylpyridine][2-2'-bi(4-tert-butylpyridine)]iridium di(hexafluorophosphate), Eosin Y or Bengal rose red; the additive is tetrabutylammonium bromide, pyridine, tetrabutylammonium hydrogen phosphate, triethylamine, lithium bromide, potassium bromide or polyethylene glycol.
[0025] Preferably, the temperature of the cyclization and regioselective bromination reaction is room temperature, and the time is 3 to 24 hours.
[0026] The present invention also provides 1,5-disubstituted-4-bromopyrazole compounds, including any one of the following structural formulas:
[0027]
[0028]
[0029] The present invention also provides the use of the 1,5-disubstituted-4-bromopyrazole compounds described in the above technical solution in the preparation of pharmaceutical or pesticide intermediates, or as pharmaceutical or pesticide preparation raw materials.
[0030] Compared with the prior art, the present invention has the following beneficial effects:
[0031] The invention provides a method for preparing 1,5-disubstituted-4-bromopyrazole compounds. The invention selects enaminone compounds, hydrazine compounds, and bromination reagents (carbon tetrabromide or NBS) as raw materials to prepare 1,5-disubstituted-4-bromopyrazole compounds. After the enaminone compounds and hydrazine compounds are connected with different substituents, they can still adapt to the reaction well, and the bromopyrazole compounds are obtained by one-pot method. The preparation method of the invention has the advantages of mild conditions, simple operation, economical steps, cheap and easy to obtain raw materials, wide substrate range, and good functional group tolerance, and the prepared 1,5-disubstituted-4-bromopyrazole compounds have a high purity of 98.5-99.9%. Compared with a multi-step synthesis reaction, the invention adopts a one-pot method to obtain the target product, and the reaction yield can reach 91%, which has the advantages of high reaction efficiency and economical steps. DETAILED DESCRIPTION
[0032] The present invention provides a method for preparing a 1,5-disubstituted-4-bromopyrazole compound, comprising the following steps:
[0033] The enaminone compound, the hydrazine compound, the bromination agent, the photocatalyst, the additive and the organic solvent are mixed to carry out a ring-forming and regioselective bromination reaction to obtain a 1,5-disubstituted-4-bromopyrazole compound;
[0034] The enaminone compound has a structure shown in Formula I, the hydrazine compound has a structure shown in Formula II, and the 1,5-disubstituted-4-bromopyrazole compound has a structure shown in Formula III:
[0035]
[0036] R1 is aryl, substituted aryl or alkyl; R2 is aryl, substituted aryl, hydrogen or acyl.
[0037] In the present invention, unless otherwise specified, the materials and equipment used are commercially available products in the art.
[0038] In the present invention, the R1 preferably includes phenyl, halogenphenyl, trifluoromethylphenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, cyanophenyl, naphthyl, biphenyl, heterocyclic group, cycloalkyl or chain alkyl; the halogenphenyl preferably includes fluorophenyl, chlorophenyl, bromophenyl or iodophenyl; the alkylphenyl preferably includes tolyl; the alkoxyphenyl preferably includes methoxyphenyl; the heterocyclic group preferably includes furyl, methylenedioxyphenyl, pyridyl, the cycloalkyl preferably includes cyclopropyl, cyclobutyl, cyclohexyl or adamantyl, and the chain alkyl preferably includes isopropyl, propyl, tridecyl.In the present invention, the enaminones preferably include (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-fluorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-chlorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-bromophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-iodophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-trifluoromethylphenyl)-2-propene-1-one, (E)- 3-(Dimethylamino)-1-(4-nitrophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(4-methoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(4-ethoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-methylphenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3-cyanophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(2 -bromophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(3,4-chlorophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-naphthyl-2-propen-1-one, (E)-3-(dimethylamino)-1-(6-methoxynaphthyl-2-yl)-2-propen-1-one, 3-(dimethylamino)-1-biphenyl-2-propen-1-one, (E)-3-(dimethylamino)-1-(benzo[d][1,3]dioxol-5-yl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(furan-2-yl)-2-propen-1-one 1-one, 3-(dimethylamino)-1-(2-pyridine)-2-propene-1-one, 3-(dimethylamino)-1-isopropyl-2-propene-1-one, 3-(dimethylamino)-1-propyl-2-propene-1-one, 3-(dimethylamino)-1-tridecyl-2-propene-1-one, 3-(dimethylamino)-1-cyclopropyl-2-propene-1-one, 3-(dimethylamino)-1-cyclobutyl-2-propene-1-one, 3-(dimethylamino)-1-cyclohexyl-2-propene-1-one or 3-(dimethylamino)-1-((3r,5r,7r)-adamantan-1-yl)-2-propene-1-one.
[0039] Introducing the thermoelectric properties of chemicals in the field of photoinduced “(1)Huo,J.andGeng,X.andLi,W.andZhang,P.andWang,L.Photoinduced Three-Component Cyclization of Arylamines,Enaminones and Difluorobromoacetates to2,3-Difunctionalized Quinolines.Adv.Synth.Catal.2022,364,3539-3543.DOI:10.1002 / adsc.202200615(2)Liang X,Guo P,Yang W,Li M,Jiang C,Sun W,Loh TP,Jiang W.Stereoselectivesynthesis of trifluoromethyl-substituted2H-furan-amines from enaminones[J].Chemical Communications,2020,56(13):2043-2046.DOI:10.1039 / C9CC08582C6(3)Qian,Y.Schürmann,M.Janning,P.Hedberg,C.Waldmann,H.Activity-Based ProteomeProfiling Probes Based on Woodward's Reagent K with Distinct TargetSelectivity.Angew.Chem.Int.Ed.,2016,55,7766-7771.DOI:10.1002 / anie.201602666(4)Stanek ,J.Caravatti,G.Capraro,H.-G.Furet,P.Mett,H.Schneider,P.Regenass,US-Adenosylmethionine Decarboxylase Inhibitors:New Aryl andHeteroaryl Analogs ofMethylglyoxal Bis(guanylhydrazone).J.Med.Chem.1993,36,46-54.DOI:10.1021 / jm00053a007;(5)Wu,W.,Wu,X.,Fan,S.Zhu,J.Rh(III)-Catalyzed Enaminone-Directed CH Coupling with Diazodicarbonyls for Skeleton-Divergent Synthesis of Isocoumarins and Naphthalenes.Org.Lett.2022,24,7850-7855.DOI:10.1021 / acs.orglett.2c03288."
[0040] In the present invention, the R2 preferably includes phenyl, halogenphenyl, cyanophenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, naphthyl, pyridyl, pyrazinyl, benzyl, hydrogen, benzenesulfonyl or isobutyric acid acyl; the halogenphenyl preferably includes fluorophenyl, chlorophenyl or bromophenyl; the alkylphenyl preferably includes tolyl; the alkoxyphenyl preferably includes methoxyphenyl.
[0041] In the present invention, the hydrazine compound preferably includes phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-trifluoromethylphenylhydrazine, 4-methoxyphenylhydrazine, 3-fluorophenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-nitrophenylhydrazine, 4-nitrophenylhydrazine, 3-methoxyphenylhydrazine, 2-methylphenylhydrazine, 2-fluorophenylhydrazine, 3,5-dimethylphenylhydrazine, 3,4-dichlorophenylhydrazine, 1-benzylhydrazine, 1-naphthyhydrazine, 2-hydrazinopyridine, 2-hydrazinopyrazine, hydrazine hydrate, benzenesulfonylhydrazine or isobutyric acid hydrazide.
[0042] In the present invention, the bromination reagent preferably includes carbon tetrabromide or N-bromosuccinimide, and the molar ratio of the enaminone compound, the hydrazine compound and carbon tetrabromide is preferably 1:(1-3):(1-3), more preferably 1:2:2.
[0043] In the present invention, the polar organic solvent preferably includes one or more of acetonitrile, ethanol, water, dimethyl sulfoxide, N,N-dimethylformamide and ethyl acetate. The amount ratio of the polar organic solvent to the enaminone compound is preferably 1L: (0.1-1) mol, more preferably 1L: 0.1 mol.
[0044] In the present invention, the photocatalyst is preferably tris(2-phenylpyridine)iridium (Ir(ppy)3), tris(2,2'-bipyridyl)ruthenium(II) chloride hexahydrate, di[2-(2,4-difluorophenyl)-5-trifluoromethylpyridine][2-2'-bi(4-tert-butylpyridine)]iridium di(hexafluorophosphate), Eosin Y or Bengal rose red, and the amount of the photocatalyst added is preferably 0.5-10 mol%, more preferably 1-3 mol%, and more preferably 2 mol% of the enaminone compound. Under photocatalysis, the bromination reagent generates bromine radicals, which attack the 4 position of the pyridine ring to obtain 4-bromo-1,5-disubstituted pyrazole. The wavelength range of light used by the photocatalyst is preferably 360-1000 nm.
[0045] In the present invention, the additive is preferably tetrabutylammonium bromide (TBAB), pyridine, tetrabutylammonium hydrogen phosphate, triethylamine, lithium bromide, potassium bromide or polyethylene glycol, and the added amount of the TBAB is preferably 10 to 100 mol%, more preferably 50 mol% of the enaminone compound.
[0046] In the present invention, the ring-forming and regioselective bromination reaction is preferably carried out at room temperature, under illumination and stirring conditions, the time is preferably 3 to 24 hours, more preferably 12 hours, the light source of the illumination is preferably blue LEDs (465nm), the intensity of the illumination is preferably 5 to 30W, more preferably 10W. The present invention has no special requirements for the stirring speed, and the speed commonly used in the art can be used to ensure the smooth progress of the reaction. The present invention mixes enaminoketone compounds, hydrazine compounds, carbon tetrabromide (CBr4), photocatalysts (Ir(ppy)3), phase transfer catalysts (TBAB) and polar organic solvents (MeCN), and adopts a one-pot method to first form a ring to form a disubstituted pyrazole (1,5-disubstituted-1H-pyrazole), and then carry out a regioselective bromination reaction of pyrazole. The electron density at the 4-position on the pyrazole ring is the largest, which is conducive to the attack of bromine radicals to obtain 1,5-disubstituted-4-bromopyrazole compounds. The reaction formula is as follows (1mL of solvent is relative to 0.1mmol of enaminoketone compounds):
[0047]
[0048] In the present invention, after the cyclization and regioselective bromination reaction, the further step is preferably to purify the obtained product system. The purification method is preferably column chromatography, and the eluent used for the column chromatography is preferably a mixed solvent of petroleum ether and ethyl acetate; the volume ratio of petroleum ether to ethyl acetate in the mixed solvent is preferably 1 to 20:1, more preferably 10 to 20:1. The present invention has no special requirements for the specific process of the column chromatography, and the method well known to those skilled in the art can be used. The present invention uses petroleum ether and ethyl acetate as eluents for purification, and the purity of the obtained target compound is relatively high, which can reach 99.9%.
[0049] The purity of the 1,5-disubstituted-4-bromopyrazole compounds prepared by the present invention is preferably 98.5-99.9%; the yield is preferably 15-91%, and more preferably 70-91%.
[0050] The present invention also provides 1,5-disubstituted-4-bromopyrazole compounds, including any one of the following structural formulas:
[0051]
[0052]
[0053] The 1,5-disubstituted-4-bromopyrazole compounds prepared by the present invention have a higher yield than that of the chlorinated compounds.
[0054] The present invention also provides the use of the 1,5-disubstituted-4-bromopyrazole compounds described in the above technical solution in the preparation of pharmaceutical or pesticide intermediates, or as pharmaceutical or pesticide preparation raw materials.
[0055] In the present invention, the 1,5-disubstituted-4-bromopyrazole compound can undergo a Suzuli coupling reaction, a Sonogashira coupling reaction, a nitro reduction reaction or an N-alkylation reaction to be converted into a pharmaceutical or pesticide product.
[0056] In order to further illustrate the present invention, the 1,5-disubstituted-4-bromopyrazole compounds provided by the present invention and their preparation methods and applications are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.
[0057] In the examples of the present invention, mol % is calculated based on enaminone compounds.
[0058] Example 1
[0059] The 4-bromo-1,5-diphenyl-1H-pyrazole compound obtained in this example has the following structure:
[0060]
[0061] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to the reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1,5-diphenyl-1H-pyrazole compound was obtained with a yield of 81% and a purity of 99.9%.
[0062] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0063] 1 H NMR (400MHz, CDCl3, ppm) δ7.77 (s, 1H), 7.38-7.34 (m, 3H), 7.29 (dd, J = 5.0, 2.8Hz, 5H), 7.23 (dd, J = 7.9, 1.9Hz, 2H).
[0064] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.0,140.4,139.8,130.0,128.9,128.8,128.5,128.4,127.6,124.7,95.8.
[0065] MS(EI,70eV)m / z 298,218,190,180,165.
[0066] Example 2
[0067] The 4-bromo-5-(4-fluorophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0068]
[0069] 0.1mmol (E)-3-(dimethylamino)-1-(4-fluorophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-5-(4-fluorophenyl)-1-phenyl-1H-pyrazole compound was obtained with a yield of 74% and a purity of 99.9%.
[0070] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0071] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.35-7.19 (m, 7H), 7.05 (t, J = 8.6Hz, 2H).
[0072] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ 164.0, 161.5, 141.0, 139.6, 139.4, 131.9 (d, J = 8.4Hz), 128.9, 127.7, 124.7, 115.8, 115.6, 95.8.
[0073] MS(EI,70eV)m / z 316,236,216,208,198.
[0074] Example 3
[0075] The 4-bromo-5-(4-chlorophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0076]
[0077] 0.1mmol (E)-3-(dimethylamino)-1-(4-chlorophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-5-(4-chlorophenyl)-1-phenyl-1H-pyrazole compound was obtained with a yield of 77% and a purity of 99.9%.
[0078] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0079] 1 H NMR (400MHz, CDCl3, ppm) δ7.76 (s, 1H), 7.35-7.28 (m, 5H), 7.21 (d, J = 8.3Hz, 4H).
[0080] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.0,139.5,139.1,135.0,131.2,128.9,128.8,127.8,126.8,124.7,95.9.
[0081] MS(EI,70eV)m / z 332,298,270,252,225.
[0082] Example 4
[0083] The 4-bromo-5-(4-bromophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0084]
[0085] 0.1mmol (E)-3-(dimethylamino)-1-(4-bromophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 4-bromo-5-(4-bromophenyl)-1-phenyl-1H-pyrazole compound, with a yield of 79% and a purity of 99.9%.
[0086] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0087] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.49 (d, J = 8.5Hz, 2H), 7.34-7.28 (m, 3H), 7.21 (dd, J = 8.0, 1.8Hz, 2H), 7.15 (d, J = 8.5Hz, 2H).
[0088] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.1,139.5,139.1,131.7,131.4,129.0,127.8,127.3,124.7,123.3,95.9.
[0089] MS(EI,70eV)m / z 378,298,271,258,218
[0090] Example 5
[0091] The 4-bromo-5-(4-iodophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0092]
[0093] 0.1mmol (E)-3-(dimethylamino)-1-(4-iodophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 4-bromo-5-(4-iodophenyl)-1-phenyl-1H-pyrazole compound, with a yield of 79% and a purity of 99.9%.
[0094] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0095] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.69 (d, J = 8.5Hz, 2H), 7.35-7.28 (m, 3H), 7.21 (dd, J = 8.0, 1.8Hz, 2H), 7.01 (d, J = 8.5Hz, 2H).
[0096] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.1,139.5,139.2,137.6,131.5,129.0,127.8,124.7,95.9,95.3.
[0097] MS(EI,70eV)m / z 424,344,318,306,298.
[0098] Example 6
[0099] The 4-bromo-5-(4-trifluoromethylphenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0100]
[0101] 0.1mmol (E)-3-(dimethylamino)-1-(4-trifluoromethylphenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 4-bromo-5-(4-trifluoromethylphenyl)-1-phenyl-1H-pyrazole compound, with a yield of 77% and a purity of 99.9%.
[0102] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0103] 1 H NMR (400MHz, CDCl3, ppm) δ7.78 (s, 1H), 7.62 (d, J = 8.2Hz, 2H), 7.41 (d, J = 8.1Hz, 2H), 7.33 (d, J = 7.5Hz, 3H), 7.20 (dd, J = 7.6, 2.1Hz, 2H).
[0104] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.3,139.4,138.8,130.3,129.1,128.1,125.49,125.45,125.41,125.38,124.8,96.3.
[0105] MS(EI,70eV)m / z 366,347,297,286,267.
[0106] Example 7
[0107] The 4-bromo-5-(4-nitrophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0108]
[0109] 0.1mmol (E)-3-(dimethylamino)-1-(4-nitrophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, and the purified target product 4-bromo-5-(4-nitrophenyl)-1-phenyl-1H-pyrazole compound was obtained with a yield of 76% and a purity of 99.9%.
[0110] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0111] 1 H NMR (400MHz, CDCl3, ppm) δ8.20(d,J=8.8Hz,2H),7.79(s,1H),7.46(d,J=8.8Hz,2H),7.34(dd,J=5.1,1.6Hz,3H),7.19(dd,J=6.8,2.9Hz,2H).
[0112] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ147.6,141.4,139.2,138.0,134.8,130.8,129.2,128.3,124.8,123.6,96.7.
[0113] MS(EI,70eV)m / z 343,313,298,285,263.
[0114] Example 8
[0115] The 4-bromo-5-(4-methoxyphenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0116]
[0117] 0.1mmol (E)-3-(dimethylamino)-1-(4-methoxyphenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-(4-methoxyphenyl)-1-phenyl-1H-pyrazole compound, with a yield of 74% and a purity of 99.9%;
[0118] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0119] 1 H NMR (400MHz, CDCl3, ppm) δ7.74 (s, 1H), 7.34-7.16 (m, 7H), 6.88 (d, J = 8.8Hz, 2H), 3.81 (s, 3H).
[0120] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ159.8,140.8,140.2,139.9,131.2,128.8,127.5,124.7,120.6,113.9,95.5,55.1.
[0121] MS(EI,70eV)m / z 328,313,285,248,234.
[0122] Example 9
[0123] The 4-bromo-5-(4-ethoxyphenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0124]
[0125] 0.1mmol (E)-3-(dimethylamino)-1-(4-ethoxyphenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-(4-ethoxyphenyl)-1-phenyl-1H-pyrazole compound, with a yield of 70% and a purity of 99.9%.
[0126] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0127] 1 H NMR (400MHz, CDCl3, ppm) δ7.74 (s, 1H), 7.32-7.22 (m, 5H), 7.18 (d, J = 8.8Hz, 2H), 6.87 (d, J = 8.8Hz, 2H), 4.03 (q, J = 7.0Hz, 2H), 1.41 (s, 3H).
[0128] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ159.2,140.8,140.3,139.9,131.2,128.8,127.4,124.6,120.4,114.3,95.5,63.4,14.7.
[0129] MS(EI,70eV)m / z 342,314,299,285,262.
[0130] Example 10
[0131] The 4-bromo-5-(3-methoxyphenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0132]
[0133] 0.1mmol (E)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction was completed, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, and the purified target product 4-bromo-5-(3-methoxyphenyl)-1-phenyl-1H-pyrazole compound was obtained, with a yield of 73% and a purity of 99.9%.
[0134] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0135] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.31 (d, J = 7.6Hz, 3H), 7.24 (dd, J = 7.6, 5.6Hz, 3H), 6.91 (d, J = 10.7Hz, 1H), 6.83 (d, J = 8.1Hz, 2H), 3.71 (s, 3H).
[0136] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ159.3,141.0,140.2,139.8,129.6,129.5,128.9,127.6,124.7,122.3,115.2,114.8,95.8,55.2.
[0137] MS(EI,70eV)m / z 328,313,298,285,248.
[0138] Embodiment 11
[0139] The 4-bromo-5-(3-cyanophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0140]
[0141] 0.1mmol (E)-3-(dimethylamino)-1-(3-cyanophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-(3-cyanophenyl)-1-phenyl-1H-pyrazole compound, with a yield of 31% and a purity of 99.9%.
[0142] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0143] 1 H NMR (400MHz, CDCl3, ppm) δ7.78 (s, 1H), 7.65 (ddd, J=5.1, 3.6, 1.6Hz, 1H), 7.60 (d, J=1 .2Hz,1H),7.49-7.46(m,2H),7.34(dd,J=5.1,1.9Hz,3H),7.18(dd,J=5.0,1.7Hz,2H).
[0144] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.3,139.1,137.9,134.2,133.2,132.3,129.9,129.4,129.2,128.3,124.8,118.0,112.9,96.4.
[0145] MS(EI,70eV)m / z 323,308,298,243,216.
[0146] Example 12
[0147] The 4-bromo-5-(2-bromophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0148]
[0149] 0.1mmol (E)-3-(dimethylamino)-1-(2-bromophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 4-bromo-5-(2-bromophenyl)-1-phenyl-1H-pyrazole compound, with a yield of 16% and a purity of 99.9%.
[0150] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0151] 1 H NMR (400MHz, CDCl3, ppm) δ7.78 (s, 1H), 7.63 (dd, J=7.9, 1.0Hz, 1H), 7.35 (td, J=7.5, 1.3Hz, 1H), 7.31-7.21 (m, 7H).
[0152] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ140.5,140.0,139.7,133.1,132.5,131.1,130.4,128.8,127.6,127.5,124.7,123.7,97.3.
[0153] MS(EI,70eV)m / z 378,297,260,231,218.
[0154] Embodiment 13
[0155] The 4-bromo-5-(3,4-dichlorophenyl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0156]
[0157] 0.1mmol (E)-3-(dimethylamino)-1-(3,4-dichlorophenyl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to the reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, and the purified target product 4-bromo-5-(3,4-dichlorophenyl)-1-phenyl-1H-pyrazole compound was obtained with a yield of 80% and a purity of 99.9%.
[0158] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0159] 1 H NMR (400MHz, CDCl3, ppm) δ7.76 (s, 1H), 7.43 (d, J = 2.0Hz, 1H), 7.41 (d, J = 8.3Hz, 1H ),7.35(d,J=7.6Hz,3H),7.21(dd,J=7.8,1.8Hz,2H),7.04(dd,J=8.3,2.0Hz,1H).
[0160] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.2,139.3,137.9,133.3,132.8,131.6,130.5,129.2,128.3,128.1,124.7,96.3.
[0161] MS(EI,70eV)m / z 366,333,286,252,224.
[0162] Embodiment 14
[0163] The 4-bromo-5-(naphthalen-1-yl)-1-phenyl 1H-pyrazole compound obtained in this example has the following structure:
[0164]
[0165] 0.1mmol (E)-3-(dimethylamino)-1-(naphthalene-1-yl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-(naphthalene-1-yl)-1-phenyl 1H-pyrazole compound, with a yield of 46% and a purity of 99.9%.
[0166] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0167] 1 H NMR (400MHz, CDCl3, ppm) δ7.95-7.88(m,3H),7.61(d,J=8.2Hz,1H),7.52-7.44(m,3H),7.35(dd,J=7.1,1.1Hz,1H),7.19-7.10(m,5H).
[0168] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ140.8,139.8,139.6,133.4,131.5,130.0,12 9.4,128.7,128.4,127.3,127.0,126.4,126.3,125.3,125.1,123.5,98.0.
[0169] MS(EI,70eV)m / z 348,269,252,241,230.
[0170] Embodiment 15
[0171] The 4-bromo-5-(5-bromo-6-methoxynaphthalen-2-yl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0172]
[0173] 0.1mmol (E)-3-(dimethylamino)-1-(6-methoxynaphthalen-2-yl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-(5-bromo-6-methoxynaphthalen-2-yl)-1-phenyl-1H-pyrazole compound, with a yield of 84% and a purity of 99.9%.
[0174] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0175] 1 H NMR(400MHz, CDCl3, ppm) δ8.15(d,J=8.9Hz,1H),7.82(d,J=1.7Hz,1H),7.81(s,1H) ,7.78(d,J=9.0Hz,1H),7.32(dd,J=8.9,1.8Hz,1H),7.29-7.23(m,6H),4.02(s,3H).
[0176] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ154.6,141.1,139.8,139.7,132.8,129.8,129.3 ,129.1,129.0,128.6,127.7,126.4,124.6,124.2,114.0,108.4,96.1,56.9.
[0177] MS(EI,70eV)m / z 458,443,415,378,362.
[0178] Example 16
[0179] The 4-bromo-5-([1,1'-biphenyl]-4-yl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0180]
[0181] 0.1mmol (E)-3-(dimethylamino)-1-([1,1'-biphenyl]-4-yl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 4-bromo-5-([1,1'-biphenyl]-4-yl)-1-phenyl-1H-pyrazole compound, with a yield of 87% and a purity of 99.9%.
[0182] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0183] 1 H NMR (400MHz, CDCl3, ppm) δ7.80 (s, 1H), 7.65-7.58 (m, 4H), 7.45 (t, J = 7.5Hz, 2H), 7.40-7.27 (m, 8H).
[0184] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.4,141.1,139.98,139.96,139.8,130.3,128.9,128.8,127.7,127.6,127.2,127.0,127.0,124.8,95.8.
[0185] MS(EI,70eV)m / z 374,294,279,267,256.
[0186] Embodiment 17
[0187] The 5-(benzo[d][1,3]dioxol-5-yl)-4-bromo-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0188]
[0189] 0.1 mmol (E)-3-(dimethylamino)-1-(benzo[d][1,3]dioxol-5-yl)-2-propene-1-one, 0.2 mmol phenylhydrazine, 0.2 mmol carbon tetrabromide, 2 mol% tri(2-phenylpyridine)iridium, 50 mol% tetrabutylammonium bromide and 1 mL acetonitrile were added to a reaction tube, and the mixture was stirred for reaction for 12 h under 10 W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 5-(benzo[d][1,3]dioxol-5-yl)-4-bromo-1-phenyl-1H-pyrazole compound, with a yield of 70% and a purity of 99.9%.
[0190] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0191] 1 H NMR (400MHz, CDCl3, ppm) δ7.73 (s, 1H), 7.34-7.23 (m, 5H), 6.79 (d, J = 8.5Hz, 1H), 6.74 (dd, J = 6.1, 1.7Hz, 2H), 5.98 (s, 2H).
[0192] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ148.1,147.6,140.9,140.1,139.8,128.9,127.6,124.6,124.3,121.9,110.1,108.5,101.4,95.8.
[0193] MS(EI,70eV)m / z 342,313,285,262,233.
[0194] Embodiment 18
[0195] The 4-bromo-5-(5-bromofuran-2-yl)-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0196]
[0197] 0.1mmol (E)-3-(dimethylamino)-1-(furan-2-yl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, to obtain the purified target product 4-bromo-5-(5-bromofuran-2-yl)-1-phenyl-1H-pyrazole compound, with a yield of 43% and a purity of 99.9%.
[0198] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0199] 1 H NMR (400MHz, CDCl3, ppm) δ7.72 (s, 1H), 7.44-7.39 (m, 3H), 7.33 (dd, J = 7.9, 1.9Hz, 2H), 6.54 (d, J = 3.4Hz, 1H), 6.37 (d, J = 3.4Hz, 1H).
[0200] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ143.5,141.2,139.9,131.1,128.9,128.4,124.7,123.5,114.6,113.0,96.0.
[0201] MS(EI,70eV)m / z 368,287,259,248,233.
[0202] Embodiment 19
[0203] The 2-(4-bromo-1-phenyl-1H-pyrazol-5-yl)pyridine compound obtained in this example has the following structure:
[0204]
[0205] 0.1mmol (E)-3-(dimethylamino)-1-(pyridin-2-yl)-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 2-(4-bromo-1-phenyl-1H-pyrazol-5-yl)pyridine compound, with a yield of 67% and a purity of 99.9%.
[0206] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0207] 1 H NMR (400MHz, CDCl3, ppm) δ8.58(d,J=5.6Hz,1H),7.76(s,1H),7.71(td,J=7.7,1.8Hz,1H),7.43(d,J=7.8Hz,1H),7.31-7.19(m,6H).
[0208] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ149.8,148.0,140.9,139.9,139.3,136.3,128.8,127.6,125.5,124.4,123.3,96.3.
[0209] MS(EI,70eV)m / z 299,219,191,179,164.
[0210] Embodiment 20
[0211] The 4-bromo-5-isopropyl-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0212]
[0213] 0.1mmol (E)-3-(dimethylamino)-1-isopropyl-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to the reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-5-isopropyl-1-phenyl-1H-pyrazole compound was obtained with a yield of 70% and a purity of 99.9%.
[0214] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0215] 1 H NMR (400MHz, CDCl3, ppm) δ7.55 (s, 1H), 7.51-7.42 (m, 3H), 7.37-7.32 (m, 2H), 3.10 (p, J = 7.1Hz, 1H), 1.34 (d, J = 7.1Hz, 6H).
[0216] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ145.0,141.2,139.6,129.1,128.7,126.2,92.0,26.1,20.4.
[0217] MS(EI,70eV)m / z 264,249,235,185,169.
[0218] Embodiment 21
[0219] The 4-bromo-5-cyclopropyl-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0220]
[0221] 0.1mmol (E)-3-(dimethylamino)-1-cyclopropyl-2-propene-1-one, 0.2mmol phenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-5-cyclopropyl-1-phenyl-1H-pyrazole compound was obtained with a yield of 76% and a purity of 99.9%.
[0222] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0223] 1 H NMR (400MHz, CDCl3, ppm) δ7.56 (s, 1H), 7.52 (d, J = 7.2Hz, 2H), 7.46 (t, J = 7.6Hz, 2H), 7.38 (t,J=7.2Hz,1H),1.77(ddd,J=8.4,5.4,3.1Hz,1H),0.91-0.85(m,2H),0.74-0.69(m,2H).
[0224] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ140.5,140.4,139.8,128.8,127.8,124.7,95.5,7.0,6.5.
[0225] MS(EI,70eV)m / z 262,247,236,222,183.
[0226] Embodiment 22
[0227] The 5-((3r,5r,7r)-adamantan-1-yl)-4-bromo-1-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0228]
[0229] 0.1 mmol (E)-3-(dimethylamino)-1-((3r,5r,7r)-adamantan-1-yl)-2-propene-1-one, 0.2 mmol phenylhydrazine, 0.2 mmol carbon tetrabromide, 2 mol% tri(2-phenylpyridine)iridium, 50 mol% tetrabutylammonium bromide and 1 mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12 h under 10 W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography, and the eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, to obtain the purified target product 5-((3r,5r,7r)-adamantan-1-yl)-4-bromo-1-phenyl-1H-pyrazole compound, with a yield of 66% and a purity of 99.9%.
[0230] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0231] 1 H NMR (400MHz, CDCl3, ppm) δ7.52 (s, 1H), 7.43 (d, J = 7.2Hz, 3H), 7.30 (dd, J = 7.9, 1.7Hz, 2H), 2.00 (d, J = 2.9Hz, 6H), 1.92 (s, 3H), 1.62 (s, 6H).
[0232] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ146.8,143.5,141.9,129.2,128.5,128.3,92.1,40.8,36.4,36.2,28.4.
[0233] MS(EI,70eV)m / z 356,315,301,287,277.
[0234] Embodiment 23
[0235] The 4-bromo-1-(4-fluorophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0236]
[0237] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-fluorophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-fluorophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 83% and a purity of 99.9%.
[0238] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0239] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.40-7.34 (m, 3H), 7.29-7.25 (m, 2H), 7.20 (dd, J = 8.9, 4.8Hz, 2H), 6.98 (t, J = 8.5Hz, 2H).
[0240] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ162.8,160.3,141.0,140.4,129.9,129.0128.5,128.2,126.5,126.4,115.9,115.6,95.8.
[0241] MS(EI,70eV)m / z 316,298,236,216,208.
[0242] Embodiment 24
[0243] The 4-bromo-1-(4-chlorophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0244]
[0245] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-chlorophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-chlorophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 56% and a purity of 99.9%.
[0246] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0247] 1 H NMR (400MHz, CDCl3, ppm) δ7.76 (s, 1H), 7.41-7.36 (m, 3H), 7.27 (d, J = 8.6Hz, 4H), 7.16 (d, J = 8.8Hz, 2H).
[0248] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.3,140.4,138.3,133.3,129.9,129.1,129.0,128.6,128.2,125.7,96.2.
[0249] MS(EI,70eV)m / z 332,298,252,226,218.
[0250] Embodiment 25
[0251] The 4-bromo-1-(4-bromophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0252]
[0253] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-bromophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-bromophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 81% and a purity of 99.9%.
[0254] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0255] 1 H NMR (400MHz, CDCl3, ppm) δ7.76 (s, 1H), 7.43-7.36 (m, 5H), 7.29-7.25 (m, 2H), 7.10 (d, J = 8.8Hz, 2H).
[0256] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.3,140.3,138.7,131.9,129.9,129.1,128.6,128.1,125.9,121.2,96.2.
[0257] MS(EI,70eV)m / z 378,298,271,258,218.
[0258] Embodiment 26
[0259] The 4-bromo-1-(4-cyanophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0260]
[0261] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-cyanophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-cyanophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 75% and a purity of 99.9%.
[0262] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0263] 1 H NMR (400MHz, CDCl3, ppm) δ7.77 (s, 1H), 7.55 (d, J = 8.7Hz, 2H), 7.43-7.37 (m, 3H), 7.33 (d, J = 8.7Hz, 2H), 7.26 (dd, J = 7.4, 2.2Hz, 2H).
[0264] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ142.7,142.0,140.5,132.7,129.7,129.4,128.7,127.8,124.2,117.8,110.7,97.3.
[0265] MS(EI,70eV)m / z 323,308,271,243,215.
[0266] Embodiment 27
[0267] The 4-bromo-1-(4-trifluoromethylphenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0268]
[0269] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-trifluoromethylphenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-trifluoromethylphenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 85% and a purity of 99.9%.
[0270] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0271] 1 H NMR (400MHz, CDCl3, ppm) δ7.78 (s, 1H), 7.62 (d, J = 8.2Hz, 2H), 7.41 (d, J = 8.1Hz, 2H), 7.37-7.30 (m, 3H), 7.20 (dd, J = 7.6, 2.1Hz, 2H).
[0272] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.3,139.4138.9,132.1,130.3,129.1,128.1,125.50,125.47,125.43,125.39,124.8,96.3.
[0273] MS(EI,70eV)m / z 366,347,297,286,260.
[0274] Embodiment 28
[0275] The 4-bromo-1-(4-methoxyphenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0276]
[0277] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-methoxyphenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the reaction was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, and the purified target product 4-bromo-1-(4-methoxyphenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 73% and a purity of 99.9%.
[0278] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0279] 1 H NMR (400MHz, CDCl3, ppm) δ7.73 (s, 1H), 7.37-7.33 (m, 3H), 7.29-7.26 (m, 2H), 7.14 (d, J = 9.0Hz, 2H), 6.80 (d, J = 9.0Hz, 2H), 3.76 (s, 3H).
[0280] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ158.8,140.5,140.2,133.0,129.9,128.7,128.4,128.3,126.1,113.9,55.3.
[0281] MS(EI,70eV)m / z 328,313,298,285,248.
[0282] Embodiment 29
[0283] The 4-bromo-1-(3-fluorophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0284]
[0285] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 3-fluorophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(3-fluorophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 86% and a purity of 99.9%.
[0286] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0287] 1 H NMR (400MHz, CDCl3, ppm) δ7.77 (s, 1H), 7.39 (dd, J = 5.1, 1.8Hz, 3H), 7.32-7.26 (m ,2H),7.23(td,J=8.2,6.2Hz,1H),7.03(dt,J=9.6,2.2Hz,1H),7.00-6.94(m,2H).
[0288] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ 163.6, 161.1, 141.3, 140.5, 130.0, 129.9, 129.1, 128.6, 128.1, 120.08, 120.05, 114.6, 114.4, 112.2, 111.9, 96.3.
[0289] MS(EI,70eV)m / z 316,236,216,208,198.
[0290] Embodiment 30
[0291] The 4-bromo-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0292]
[0293] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 3-nitrophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(3-nitrophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 69% and a purity of 99.9%.
[0294] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0295] 1 H NMR (400MHz, CDCl3, ppm) δ8.16 (t, J=2.1Hz, 1H), 8.12 (ddd, J=8.0, 2.2, 1.2Hz, 1H), 7.81 ( s,1H),7.51(d,J=8.9Hz,1H),7.46(d,J=8.0Hz,1H),7.44-7.40(m,3H),7.31-7.26(m,2H).
[0296] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ148.3,142.0,140.8,140.6,129.9,129.7,129.6,129.0,127.8,122.0,119.3,97.2.
[0297] MS(EI,70eV)m / z 343,326,313,298,271.
[0298] Embodiment 31
[0299] The 4-bromo-1-(4-bromo-3-methoxyphenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0300]
[0301] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 4-bromo-3-methoxyphenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(4-bromo-3-methoxyphenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 34% and a purity of 99.9%.
[0302] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0303] 1 H NMR (400MHz, CDCl3, ppm) δ7.75 (s, 1H), 7.43-7.37 (m, 4H), 7.31-7.26 (m, 2H), 6.78 (d, J = 2.3Hz, 1H), 6.69 (dd, J = 8.5, 2.4Hz, 1H), 3.66 (s, 3H).
[0304] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ155.9,141.2,140.5,139.9,133.1,129.9,129.1,128.7,128.5,117.3,110.5,108.4,96.3,56.1.
[0305] MS(EI,70eV)m / z 408,328,312,299,285.
[0306] Embodiment 32
[0307] The 4-bromo-1-(2-methylphenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0308]
[0309] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 2-methylphenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(2-methylphenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 88% and a purity of 99.9%.
[0310] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0311] 1 H NMR (400MHz, CDCl3, ppm) δ7.77 (s, 1H), 7.26 (dq, J = 13.6, 3.7, 3.2Hz, 6H), 7.21-7.15 (m, 3H), 1.98 (s, 3H).
[0312] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.4,140.8,139.0,135.3,130.9,129.4,129.1,128.7,128.2,128.1,128.0,126.4,94.0,17.5.
[0313] MS(EI,70eV)m / z 312,297,284,223,218.
[0314] Embodiment 33
[0315] The 4-bromo-1-(2-fluorophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0316]
[0317] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 2-fluorophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the reaction was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(2-fluorophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 75% and a purity of 99.9%.
[0318] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0319] 1 H NMR (400MHz, CDCl3, ppm) δ7.80 (s, 1H), 7.40 (td, J = 7.7, 1.7Hz, 1H), 7.37-7.25 (m, 6H), 7.18 (t, J = 7.7Hz, 1H), 7.04 (t, J = 9.2Hz, 1H).
[0320] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ157.6,155.1,142.2,141.8,130.5,130.4,129.3,128.9,128.7,128.3,124.6,116.7,116.5,94.9.
[0321] MS(EI,70eV)m / z 316,296,236,217,198.
[0322] Embodiment 34
[0323] The 4-bromo-1-(3,5-dimethylphenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0324]
[0325] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 3,5-dimethylphenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to the reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the reaction was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(3,5-dimethylphenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 91% and a purity of 99.9%.
[0326] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0327] 1 H NMR (400MHz, CDCl3, ppm) δ7.73 (s, 1H), 7.38-7.34 (m, 3H), 7.28 (dd, J = 6.6, 3.1Hz, 2H), 6.90 (s, 1H), 6.82 (s, 2H), 2.21 (s, 6H).
[0328] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ140.7,140.3,139.6,138.6,129.9,129.2,128.8,128.6,128.3,122.4,95.4,21.1.
[0329] MS(EI,70eV)m / z 326,312,246,232,219.
[0330] Embodiment 35
[0331] The 4-bromo-1-(3,4-dichlorophenyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0332]
[0333] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 3,4-dichlorophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to the reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-(3,4-dichlorophenyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 90% and a purity of 99.9%.
[0334] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0335] 1 H NMR (400MHz, CDCl3, ppm) δ7.76 (s, 1H), 7.46 (d, J = 2.5Hz, 1H), 7.42 (dd, J = 5.1, 1 .8Hz,3H),7.31(d,J=8.7Hz,1H),7.30-7.26(m,2H),6.96(dd,J=8.7,2.5Hz,1H).
[0336] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.7,140.6,138.9,133.0,131.6,130.3,129.9,129.4,128.8,127.9,126.2,123.4,96.7.
[0337] MS(EI,70eV)m / z 366,332,286,252,226.
[0338] Embodiment 36
[0339] The 4-bromo-1-(1-naphthyl)-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0340]
[0341] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 1-naphthylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1, and the purified target product 4-bromo-1-(1-naphthyl)-5-phenyl-1H-pyrazole compound was obtained with a yield of 85% and a purity of 99.9%.
[0342] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0343] 1 H NMR (400MHz, CDCl3, ppm) δ7.92 (s, 1H), 7.87 (dd, J = 8.8, 5.5Hz, 2H), 7.65-7.60 (m, 1H), 7 .54-7.48(m,2H),7.39-7.34(m,1H),7.26(dd,J=7.3,1.1Hz,1H),7.20(q,J=7.9Hz,5H).
[0344] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ142.5,141.2,136.1,134.0,130.2,129.4,12 9.3,128.7,128.1,128.0,128.0,127.3,126.6,125.6,124.7,122.9,94.4.
[0345] MS(EI,70eV)m / z 348,268,241,230,215.
[0346] Embodiment 37
[0347] The 2-(4-bromo-5-phenyl-1H-pyrazol-1-yl)pyridine compound obtained in this example has the following structure:
[0348]
[0349] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 2-hydrazinopyridine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 2-(4-bromo-5-phenyl-1H-pyrazol-1-yl)pyridine compound was obtained with a yield of 27% and a purity of 99.9%.
[0350] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0351] 1 H NMR (400MHz, CDCl3, ppm) δ8.32(d,J=3.8Hz,1H),7.79(s,1H),7.72(td,J=7.9,1.9H z,1H),7.40-7.34(m,4H),7.30(dd,J=6.7,3.1Hz,2H),7.20(dd,J=7.4,4.9Hz,1H).
[0352] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ151.9,148.5,141.7,140.8,138.2,129.8,128.9,128.7,128.2,122.7,118.3,97.0.
[0353] MS(EI,70eV)m / z 299,274,248,220,194.
[0354] Embodiment 38
[0355] The 4-bromo-1-benzyl-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0356]
[0357] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol 1-benzylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1, and the purified target product 4-bromo-1-benzyl-5-phenyl-1H-pyrazole compound was obtained with a yield of 62% and a purity of 99.9%.
[0358] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0359] 1 H NMR (400MHz, CDCl3, ppm) δ7.63 (s, 1H), 7.47-7.43 (m, 3H), 7.32-7.24 (m, 5H), 7.01 (dd, J = 7.5, 1.9Hz, 2H), 5.26 (s, 2H).
[0360] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.6,139.8,136.7,129.9,129.3,128.7,128.6,128.3,127.7,127.0,94.0,54.2.
[0361] MS(EI,70eV)m / z 312,299,235,218,204.
[0362] Embodiment 39
[0363] The 4-bromo-5-phenyl-1H-pyrazole compound obtained in this example has the following structure:
[0364]
[0365] 0.1mmol (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, 0.2mmol hydrazine hydrate, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the mixture was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 5:1. The target products obtained after purification were all 4-bromo-5-phenyl-1H-pyrazole compounds with a yield of 58% and a purity of 99.9%.
[0366] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0367] 1 H NMR (400MHz, CDCl3, ppm) δ7.80-7.72 (m, 2H), 7.54 (s, 1H), 7.43 (q, J = 5.8Hz, 3H).
[0368] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ144.3,136.6,129.6,128.8,128.6,127.5,92.1.
[0369] MS(EI,70eV)m / z 222,195,170,142,116.
[0370] When hydrazine hydrate is replaced by benzenesulfonyl hydrazide, the yield of the target product is 18%; when hydrazine hydrate is replaced by isobutyric acid hydrazide, the yield of the target product is 25%.
[0371] Application Example 1
[0372] The 4-bromo-1,5-diphenyl-1H-pyrazole prepared in Example 1 was used to prepare a 4-(4-fluorophenyl)-1,5-diphenyl-1H-pyrazole compound, and the product structure was as follows:
[0373]
[0374] 0.1mmol 4-bromo-1,5-diphenyl-1H-pyrazole, 0.15mmol 4-fluorophenylboric acid, 20mol% palladium acetate, 40mol% triphenylphosphine, 1.6 equivalents of potassium phosphate and 1mL toluene were added to the reaction tube. Under N2 atmosphere, the mixture was refluxed in an oil bath at 80°C for 24 hours. After the reaction, it was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and dichloromethane. The volume ratio of petroleum ether to dichloromethane in the eluent was 1:1. The purified target products were all 4-(4-fluorophenyl)-1,5-diphenyl-1H-pyrazole compounds with a yield of 57% and a purity of 99.9%.
[0375] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0376] 1 H NMR (400MHz, CDCl3, ppm) δ7.88 (s, 1H), 7.33-7.24 (m, 8H), 7.19-7.12 (m, 4H), 6.95 (t, J = 8.8Hz, 2H).
[0377] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ161.6 (d, J = 244.0Hz), 139.8, 139.5, 139.1, 130.3, 129.9, 129.4 (d ,J=8.0Hz),128.8(d,J=4.0Hz),128.7,128.6,128.5,127.2,125.1,121.5,115.3(d,J=21.0Hz).
[0378] MS(EI,70eV)m / z 314,295,286,257,237.
[0379] Application Example 2
[0380] The 4-bromo-5-(4-iodophenyl)-1-phenyl-1H-pyrazole prepared in Example 5 was used to prepare a 4-bromo-1-phenyl-5-(4-(phenylethynyl)phenyl)-1H-pyrazole compound, and the product structure is as follows:
[0381]
[0382] 0.1mmol 4-bromo-5-(4-iodophenyl)-1-phenyl-1H-pyrazole, 0.12mmol benzyne, 10mol% cuprous iodide, 5mol% bis(triphenylphosphine)dichloropalladium, 0.5mL triethylamine and 1mL tetrahydrofuran were added to a reaction tube. Under a N2 atmosphere, the mixture was refluxed in an oil bath at 50°C for 24 hours. After the reaction was completed, it was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 10:1. The purified target products were all 4-bromo-1-phenyl-5-(4-(phenylethynyl)phenyl)-1H-pyrazole compounds with a yield of 89% and a purity of 99.9%.
[0383] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0384] 1 H NMR (400MHz, CDCl3, ppm) δ7.78 (s, 1H), 7.55-7.51 (m, 4H), 7.37-7.24 (m, 10H).
[0385] 13 C{ 1 H}NMR (100MHz, CDCl3, ppm) δ141.2,139.7,131.7,130.0,129.1,128.6,128.5,128.2,127.9,124.8,123.9,122.9,96.1,91.0,88.8.
[0386] MS(EI,70eV)m / z 398,318,291,280,263.
[0387] Embodiment 40
[0388] The 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole compound obtained in this example has the following structure:
[0389]
[0390] 0.1mmol (E)-3-(dimethylamino)-1-(4-methoxyphenyl)-2-propene-1-one, 0.2mmol 4-nitrophenylhydrazine, 0.2mmol carbon tetrabromide, 2mol% tri(2-phenylpyridine)iridium, 50mol% tetrabutylammonium bromide and 1mL acetonitrile were added to a reaction tube, and the reaction was stirred for 12h under 10W blue LEDs. After the reaction, the mixture was separated and purified by column chromatography. The eluent used for the column chromatography was a mixed solvent of petroleum ether and ethyl acetate. The volume ratio of petroleum ether to ethyl acetate in the eluent was 20:1. The purified target products were all 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole compounds with a yield of 81% and a purity of 99.9%.
[0391] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0392] 1 H NMR (400MHz, DMSO-d6) δ8.23(d,J=9.1Hz,2H),8.06(s,1H),7.47(d,J=9.1Hz,2H),7.24(d,J=8.8Hz,2H),7.02(d,J=8.8Hz,2H),3.79(s,3H).
[0393] 13 C{ 1 H}NMR(100MHz,DMSO-d6)δ160.0,145.8,144.2,142.0,140.8,131.3,124.9,124.6,119.5,114.4,96.8,55.3.
[0394] MS(EI,70eV)m / z 371,357,342,315,292.
[0395] Application Example 3
[0396] The 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole prepared in Example 40 was used to prepare a 4-(4-bromo-5-(4-methoxyphenyl)-1H-pyrazol-1-yl)aniline compound, and the product structure is as follows:
[0397]
[0398] 0.1mmol 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole, 5mol% Pd / C and 1mL methanol were added to the reaction tube, and the mixture was refluxed in an oil bath at 25°C for 12 hours under H2 atmosphere (1.0 atmospheric pressure). After the reaction, column chromatography was used for separation and purification, and the eluent used for column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether and ethyl acetate in the eluent was 10:1. The purified target products were all 4-(4-bromo-5-(4-methoxyphenyl)-1H-pyrazol-1-yl)aniline compounds, with a yield of 49% and a purity of 99.9%;
[0399] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0400] 1 H NMR(400MHz,DMSO-d6)δ7.78(s,1H),7.17(d,J=8.6Hz,2H),6.94(d,J=8.8Hz ,2H),6.86(d,J=8.5Hz,2H),6.49(d,J=8.4Hz,2H),5.33(s,2H),3.75(s,3H).
[0401] 13 C{ 1 H}NMR(100MHz,DMSO-d6)δ159.3,148.6,139.9,139.4,131.2,128.5,126.3,120.4,113.9,113.3,93.6,55.1.
[0402] MS(EI,70eV)m / z 343,328,312,302,264.
[0403] Application Example 4
[0404] The 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole prepared in Example 40 was used to prepare a 4-(4-bromo-5-(4-methoxyphenyl)-3-methyl-1H-pyrazol-1-yl)aniline compound, and the product structure is as follows:
[0405]
[0406] 0.1mmol 4-bromo-5-(4-methoxyphenyl)-1-(4-nitrophenyl)-1H-pyrazole, 5mol% Pd / C and 1mL methanol were added to the reaction tube, and the mixture was refluxed in an oil bath at 25°C for 12 hours under H2 atmosphere (1.0 atm). After the reaction, column chromatography was used for separation and purification, and the eluent used for column chromatography was a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether and ethyl acetate in the eluent was 10:1. The purified target products were all 4-(4-bromo-5-(4-methoxyphenyl)-3-methyl-1H-pyrazol-1-yl)aniline compounds, with a yield of 13% and a purity of 99.9%;
[0407] The structure of the obtained product was characterized, and the structural characterization data are as follows:
[0408] 1 H NMR (400MHz, DMSO-d6) δ7.79 (s, 1H), 7.17 (d, J = 8.8Hz, 2H), 6.96-6.92 (m, 4H), 6 .45(d,J=8.8Hz,2H),5.93(d,J=4.8Hz,1H),3.75(s,3H),2.64(d,J=4.5Hz,3H).
[0409] 13 C{ 1 H}NMR(100MHz,DMSO-d6)δ159.3,149.5,139.9,139.4,131.2,128.3,126.3,120.4,113.9,111.0,93.6,55.1,29.6.
[0410] MS(EI,70eV)m / z 357,342,327,315,278.
[0411] Although the above-mentioned embodiments have made a detailed description of the present invention, they are only some embodiments of the present invention, rather than all embodiments. People can also obtain other embodiments based on the embodiments of the present invention without creative work, and these embodiments all fall within the scope of protection of the present invention.
Claims
1. A method for preparing a 1,5-disubstituted-4-bromopyrazole compound, characterized in that: The following steps are involved: An enaminone compound, a hydrazine compound, a bromination agent, a photocatalyst, an additive and a polar organic solvent are mixed to carry out a ring-forming and regioselective bromination reaction to obtain a 1,5-disubstituted-4-bromopyrazole compound; The enaminone compound has a structure shown in Formula I, the hydrazine compound has a structure shown in Formula II, and the 1,5-disubstituted-4-bromopyrazole compound has a structure shown in Formula III: R1 is aryl, substituted aryl or alkyl; R2 is aryl, substituted aryl, hydrogen or acyl.
2. The preparation method according to claim 1, characterized in that: The R1 includes phenyl, halogenphenyl, trifluoromethylphenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, cyanophenyl, naphthyl, biphenyl, methylenedioxyphenyl, furyl, pyridyl, isopropyl, propyl, tridecyl, cyclopropyl, cyclobutyl, cyclohexyl or adamantyl.
3. The preparation method according to claim 1 or 2, characterized in that: The enaminones include (E)-3-(dimethylamino)-1-phenyl-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-fluorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-chlorophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-bromophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-iodophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-trifluoromethylphenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-trifluoromethylphenyl)-2-propene-1-one, and (E)-3-(dimethylamino)-1-(4-chlorophenyl)-2-propene-1-one. 1-(4-nitrophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-methoxyphenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(4-ethoxyphenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(3-methylphenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(3-cyanophenyl)-2-propene-1-one, (E)-3-(dimethylamino)-1-(2-bromophenyl)- )-2-propen-1-one, (E)-3-(dimethylamino)-1-(3,4-chlorophenyl)-2-propen-1-one, (E)-3-(dimethylamino)-1-naphthyl-2-propen-1-one, (E)-3-(dimethylamino)-1-(6-methoxynaphthyl-2-yl)-2-propen-1-one, 3-(dimethylamino)-1-biphenyl-2-propen-1-one, (E)-3-(dimethylamino)-1-(benzo[d][1,3]dioxol-5-yl)-2-propen-1-one, (E)-3-(dimethylamino)-1-(furan-2-yl)-2-propen-1-one, 3-(dimethylamino)-1-(2-pyridine)-2-propene-1-one, 3-(dimethylamino)-1-isopropyl-2-propene-1-one, 3-(dimethylamino)-1-propyl-2-propene-1-one, 3-(dimethylamino)-1-tridecyl-2-propene-1-one, 3-(dimethylamino)-1-cyclopropyl-2-propene-1-one, 3-(dimethylamino)-1-cyclobutyl-2-propene-1-one, 3-(dimethylamino)-1-cyclohexyl-2-propene-1-one or 3-(dimethylamino)-1-((3r, 5r, 7r)-adamantan-1-yl)-2-propene-1-one.
4. The preparation method according to claim 1, characterized in that: The R2 includes phenyl, halophenyl, cyanophenyl, alkylphenyl, alkoxyphenyl, nitrophenyl, naphthyl, pyridyl, pyrazinyl, benzyl, hydrogen, phenylsulfonyl or isobutyric acid acyl.
5. The preparation method according to claim 1 or 4, characterized in that: The hydrazine compound includes phenylhydrazine, 4-fluorophenylhydrazine, 4-chlorophenylhydrazine, 4-bromophenylhydrazine, 4-cyanophenylhydrazine, 4-trifluoromethylphenylhydrazine, 4-methoxyphenylhydrazine, 3-fluorophenylhydrazine, 3-chlorophenylhydrazine, 3-bromophenylhydrazine, 3-nitrophenylhydrazine, 4-nitrophenylhydrazine, 3-methoxyphenylhydrazine, 2-methylphenylhydrazine, 2-fluorophenylhydrazine, 3,5-dimethylphenylhydrazine, 3,4-dichlorophenylhydrazine, 1-benzylhydrazine, 1-naphthyhydrazine, 2-hydrazinopyridine, 2-hydrazinopyrazine, hydrazine hydrate, benzenesulfonylhydrazine or isobutyric acid hydrazide.
6. The preparation method according to claim 1, characterized in that: The bromination reagent includes carbon tetrabromide or N-bromosuccinimide, and the molar ratio of the enaminone compound, the hydrazine compound and carbon tetrabromide is 1:(1-3):(1-3).
7. The preparation method according to claim 1, characterized in that: The photocatalyst is tris(2-phenylpyridine)iridium, tris(2,2'-bipyridyl)ruthenium(II) chloride hexahydrate, di[2-(2,4-difluorophenyl)-5-trifluoromethylpyridine][2-2'-bi(4-tert-butylpyridine)]iridium di(hexafluorophosphate), Eosin Y or Bengal rose red; the additive is tetrabutylammonium bromide, pyridine, tetrabutylammonium hydrogen phosphate, triethylamine, lithium bromide, potassium bromide or polyethylene glycol.
8. The preparation method according to claim 1, characterized in that: The temperature of the ring-forming and regioselective bromination reaction is room temperature, and the time is 3 to 24 hours.
9. 1,5-disubstituted-4-bromopyrazole compounds, characterized in that: Including any of the following structural formulas:
10. Use of the 1,5-disubstituted-4-bromopyrazole compound according to claim 9 in the preparation of pharmaceutical or pesticide intermediates, or as a raw material for the preparation of pharmaceuticals or pesticides.
Citation Information
Patent Citations
Herbicidal pyrazoles
GB1483162A
Pyrazole-based compound, electron-transporting material, material for organic electroluminescent element and organic electroluminescent element
JP2004331588A
